Table 2 Postoperative outcomes
From: Perioperative redox changes in patients undergoing hepato-pancreatico-biliary cancer surgery
Postoperative outcome | N (%) | |
|---|---|---|
Clavien Dindo | Severity category | |
No complications | 1 (1.8%) | }Mild: 13 (23.2%) |
I | 12 (21.4%) | |
II | 27 (48.2%) | Moderate: 27 (48.2%) |
IIIa | 3 (5.4%) | }Severe: 16 (28.6%) |
IIIb | 1 (1.8%) | |
IVa | 10 (17.9%) | |
IVb | 1 (1.8%) | |
V | 1 (1.8%) | |
Median (IQR) number of ICU days | 2.0 (1.0–2.8) | / |
Number of ICU readmission | 5 (8.9%) | / |
Median (IQR) number of hospital days | 9.0 (6.2–14.8) | / |
Survival at 90 days | 50 (89.3%) | / |